1. Introduction
===============

Conventional laparoscopic surgery is considered to be the conventional therapy for patients with non-small cell lung cancer (NSCLC). It allows more rapid postoperative recovery and has superior cosmetic outcomes, while it still has several technical drawbacks such as high morbidity and long postoperative stays.^\[[@R1]\]^

The last 2 decades have witnessed minimally invasive techniques, that is, video-assisted thoracic surgery (VATS) the rise in popularity and has been widely applied for lung cancer. Since VATS lobectomy was first performed in the early 1990s.^\[[@R2],[@R3]\]^

Previous studies have demonstrated clear benefits of VATS superior to the traditional lobectomy by thoracotomy approach for early-stage NSCLC, including shorter length of hospital stay, improved recovery, fewer perioperative complications,^\[[@R4]--[@R6]\]^ and improved long-term survival for selected patients.^\[[@R7],[@R8]\]^ However, the development of this technique be limited by some shortcomings such as steep learning curve, difficult hand--eye coordination, or lack of instrument flexibility.^\[[@R9]\]^

Robot-assisted thoracic surgery (RATS) is a relatively new platform for minimally invasive lung lobectomy. It has been proposed as an alternative to VATS. RATS lobectomy appears to present some advantages over VATS approach,^\[[@R10]--[@R12]\]^ including three-dimensional optics, small-wristed instrument motions, which can facilitate complex movements in a closed space, and influences both intraoperative complication and postoperative outcomes.^\[[@R13]--[@R15]\]^ On the other hand, in spite of the aforementioned advantages of RLS there are several controversial aspects of this approach, such as higher hospital costs and longer procedure times may restrict the RATS.^\[[@R16]\]^

A relatively new minimally invasive technique introduced to thoracic surgery is using the robotic Da Vinci surgical system. Several studies^\[[@R15],[@R17]\]^ have showed Introduced for robotic-assisted thoracoscopy the Da Vinci Surgical System the feasibility and safety of this novel technique for lobectomy.

Despite a growing body of literature regarding robotic lobectomy, there is a paucity of information on whether or not there are advantages to transitioning to robotics by surgeons who are already proficient in performing VATS lobectomy.^\[[@R18]\]^

For these reasons, combined to a very effective marketing campaign, the widespread enthusiasm for this technology led to a quick rise of both surgeon\'s utilization and patients' demand. To clarify the value of robotic thymectomy, a systematic literature review and meta-analysis was performed of all relevant comparative studies to compare surgical outcomes of VATS and RATS in terms of surgical and short-term outcomes.

2. Methods and materials
========================

2.1. Search strategy
--------------------

PubMed and Embase databases were searched to identify studies assessing the comparison between Da Vinci-RATS and VATS among lung cancer patients. Two investigators independently searched up to December 2017. The process was established to find all articles with the keywords: "video-assisted thoracic surgery" and "robotics OR robot OR robotic surgery OR computer-assisted surgery OR da Vinci," and relevant Medical Subject Heading (MeSH) terms were utilized. The reference lists of all articles that dealt with the topic of interest were also hand-searched to check for additional relevant publications.

2.2. Eligibility criteria
-------------------------

Studies were included in the meta-analysis should meet the following criteria: the studies are designed as trials comparing Da Vinci-RATS to VATS; comparisons of outcomes of patients with NSCLC patients; and the outcomes of interest were perioperative morbidity or mortality for both Da Vinci-RATS and VATS, and HRs with corresponding 95% CIs were provided. Studies without data on the outcomes were excluded.

2.3. Quality assessment
-----------------------

Two investigators separately rated the quality of the retrieved studies. Study quality was assessed using Newcastle--Ottawa quality assessment scale.

2.4. Data extraction
--------------------

From each of the eligible studies, the main categories based on the following: first author family name, publication year, study design, study period, surgical technique for Da Vinci-RATS or VATS lobectomy, number of patients, geographic location, intraoperative parameters (operative time and conversion), and postoperative parameters (dissected lymph nodes number, hospital length of stay, duration of drainage \[days\], prolonged air leak, and composite morbidity). Data were extracted by 2 authors independently. Disagreement was resolved by consensus.

2.5. Statistical analysis
-------------------------

Meta-analysis was performed by pooling the results of reported incidence of intraoperative parameters and postoperative parameters. Results will be expressed as mean differences for continuous outcomes (standardized vs. weighted to be determined by available data); and the appropriate ratio/difference for dichotomous outcomes as determined by available data.

A sensitivity analysis was also performed to examine the impact on the overall results, depending on the heterogeneity across the included studies. The heterogeneity across studies was examined the *I*^2^ statistic.^\[[@R19]\]^*I*^2^ \> 50% suggested high degree of heterogeneity, and \<50% suggested low degree of heterogeneity, respectively.^\[[@R20]\]^ When there was low heterogeneity among studies, the fixed-effects model was used. Otherwise, the random effects model was used. *P* \< .05 was identified as statistically significant difference. The statistical analyses were performed using Review Manager version 5.3 software (RevMan; The Cochrane collaboration, Oxford, UK). Findings of our meta-analysis were shown in forest plots. The Begg test and the Egger test were conducted to evaluate publication bias.

2.6. Ethical Approval
---------------------

The ethical approval was not necessary because our study was a meta-analysis that belongs to secondary researches.

3. Results
==========

3.1. Overview of literature search and study characteristics
------------------------------------------------------------

Through the literature search in PubMed and Embase databases, we found a total of 452 individual records. Based on the criteria described in the methods, 19 publications were evaluated in more detail, but some did not provide enough detail of outcomes of 2 approaches. Therefore, a final total of 14^\[[@R21]--[@R33]\]^ retrospective cohort studies were included in this meta-analysis. The search process is described in Figure [1](#F1){ref-type="fig"}.

![PRISMA flow chart of selection process to identify studies eligible for pooling.](medi-98-e17089-g001){#F1}

All included studies in this study were based on moderate to high-quality evidence. Table [1](#T1){ref-type="table"} describes the primary characteristics of the eligible studies in more detail.

###### 

The primary characteristics of the eligible studies in more detail.

![](medi-98-e17089-g002)

3.2. Clinical and methodological heterogeneity
----------------------------------------------

Pooled analysis of conversion to open after RATS vs. VATS for lung cancer:

The pooling analysis revealed that there was not statistically significant difference in conversion to open between RATS and VATS lobectomy (RR = 1.03, 95% CI 0.54--1.99; *P* = .92) (Fig. [2](#F2){ref-type="fig"}).

![Pooled analysis of conversion to open after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g003){#F2}

Pooled analysis of operative time after RATS vs. VATS for lung cancer:

A random-effects model was used to pool the operative time data, since the heterogeneity across the 3 studies was significant high. The pooled data showed that robotic resection was not associated with prolong the operative time (SMD = 0.18, 95% CI = −1.46--1.82, *P* = .083) than VATS treatment (Fig. [3](#F3){ref-type="fig"}).

![Pooled analysis of operative time after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g004){#F3}

Pooled analysis of hospital length of stay after RATS vs. VATS for lung cancer:

Hospital length of stay was available for 3 studies. Results showed that there was no benefit after RATS vs. VATS for lung cancer (MD = 0.29, 95% CI = −0.55--1.13, *P* = .49) (Fig. [4](#F4){ref-type="fig"}).

![Pooled analysis of hospital length of stay after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g005){#F4}

Pooled analysis of dissected lymph nodes number after RATS vs. VATS for lung cancer:

In the analysis of dissected lymph nodes number in patients with comparing RATS with VATS, 5 studies were included, and the data are shown in Figure [5](#F5){ref-type="fig"}. While the data does not reach a statistically significant level (MD = 0.87, 95% CI = −1.14--2.88, *P* = .39).

![Pooled analysis of dissected lymph nodes station after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g006){#F5}

Pooled analysis of the mean duration of drainage after RATS vs. VATS for lung cancer:

The mean duration of drainage of the RATS compare with VATS in 3 studies (Fig. [6](#F6){ref-type="fig"}). Results showed that there was no statistically significant in terms of it (MD = 0.29, 95% CI = −0.15--0.73, *P* = .20).

![Pooled analysis of the mean duration of drainage after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g007){#F6}

Pooled analysis of the incidence of prolonged air leak after RATS vs. VATS for lung cancer:

Pooling the data from 3 studies showed that RATS did not prolong air leak (RR = 1.44, 95% CI = 0.80--2.57; *P* = .22) compared with the VATS group (Fig. [7](#F7){ref-type="fig"}).

![Pooled analysis of the incidence of prolonged air leak after RATS vs. VATS for lung cancer. RATS = robot-assisted thoracic surgery, VATS = video-assisted thoracic surgery.](medi-98-e17089-g008){#F7}

Pooled analysis of postoperative morbidity rate comparing robotic-assisted vs. laparoscopic surgery:

The pooled data showed that robotic-assisted surgery did not decrease the postoperative morbidity rate (OR = 1.26; 95% CI = 0.90--1.78; *P* = .18) with laparoscopic surgery (Fig. [8](#F8){ref-type="fig"}).

![Pooled analysis of postoperative morbidity rate comparing robotic-assisted vs. laparoscopic surgery.](medi-98-e17089-g009){#F8}

4. Discussion
=============

The use of robotics represents an alternative invasive approach, compared with VATS and thoracotomy.^\[[@R34]\]^ The "da Vinci system" has been increasing used for thoracic surgical procedures.^\[[@R35]--[@R38]\]^ Telerobotics improved dexterity by an active filtration of surgeon tremors, with ergonomic advantages, such as three-dimensional high-definition visualization, high-resolution magnification of the surgical field, and better maneuverability of instruments.^\[[@R39]\]^ However, the drawback of the "da Vinci system" is health costs and profits, lack of haptic feedback, and debate regarding the management of intraoperative bleeding.

Our analysis revealed that RATS lobectomy did not reduce the mobility rate when compared with VATS lobectomy, and this was consistent with the pooled result of the meta-analysis.^\[[@R40]\]^ Moreover, no statistically significant differences were observed in the incidence of intraoperative parameters and postoperative parameters when comparing RATS to VATS lobectomy.

While, clinical heterogeneity introduced by integrating various surgical procedures may affect the result, presumably reflecting the intrinsic properties of each surgical procedure such as retroperitoneal involvement of prostatectomy.^\[[@R41]\]^

These outcomes suggest that RATS lobectomy is a safe and feasible surgical approach for patients with lung cancer and can achieve an equivalent short-term surgical efficacy compared with VATS lobectomy.

The transition from VATS minimally invasive techniques to robotic surgery happened limit imposed by heterogeneities, which diminished the significance of the statistical results of weighing advantages and disadvantages. The difference of indications across studies could have resulted in the inclusion of patients from each study variable. For example, in addition to the apparent discrepancy between the patient\'s conditions and clinical indications.

With respect to the operative results, most included studies reported a longer operative time for RATS compared to VATS lobectomy.^\[[@R21],[@R42],[@R43]\]^ This can be explained by several potential factors. Taking into account its easier maneuverability, the robotic surgical system prolong the operative time by setting up the robotic system. But the short-term morbidity and mortality for patients did not increase in robotic surgery, which means that robotic surgery did not have negative impact on postoperative results.

However, due to the retrospective nature of this study, there were no enough reliable data about the operative cost. The lack of these data is a limitation of the study.

Although the present study demonstrates analysis of comparisons of VATS vs. RATS reported similar results there may be more reasons under debate. First, these benefits derive from the better depth visualization of RATS and increase in visual strain for surgeons. This influences both intraoperative complication^\[[@R44]\]^ and conversion rates.^\[[@R45]\]^ Second, robotic technology will continue to develop, and with the clearly delineated benefits of robotic surgery, like the wristed movements of the robotic instruments combined with the enhanced field of vision and the benefit of VATS were potentially combined.

This study still has several limitations, the most important of which is its retrospective nature, data included in the present meta-analysis were extrapolated from retrospective cohort studies, and bias might also exist due to the retrospective nature of the study. Furthermore, because of limited data on the cost, we did not compare costs, but the cost of robotic technology, especially in a time of increasing healthcare expenditures, may be a real issue. Nevertheless, we believe that with advances in the robotic technique, the device-related costs will decrease. Finally, it is worth mentioning that personal surgeons' preference played an important role in treatment.

5. Conclusion
=============

In conclusion, our data suggest that Da Vinci-RATS lobectomy is a feasible and safe technique and can achieve an equivalent surgical efficacy when compared with VATS. Every procedure in medicine has its own indications, and the role of robotic surgery remains unclear. Hence, future studies should emphasize the rigorous eligibility criteria, clear definition of outcomes. Needless to say, approaching segmentectomy with minimally invasive techniques adds a further layer of complexity. We strongly believe that the advantages in dexterity and depth of visualization delivered by the robot facilitate execution of more complex procedures, therefore allowing for anatomical resection in patients who benefit from lung preservation.
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